L-Carnitine
Natural health product licensed in Canada
- Licence holder
- RX BALANCE TECHNOLOGY INC.
- NPN or DIN-HM
- 80041412
- Status
- Active licence
- Licence date
- 4 April 2013
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Gélatine, Dioxyde de silicium, Stéarate de magnésium, Phosphate de calcium, dibasique, Cellulose microcristalline
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 6 Capsule | 1 day |
| Adultes | Not specified | 3 Capsule | 1 day |
Uses authorised in Canada
At 1020 mg (3 capsules) daily: Supports cellular energy metabolism. At 1020 mg (3 capsules) daily: Athletic support/Workout supplement. At 1020 mg (3 capsules) daily: Aids in the muscle recovery process by reducing muscle tissue damage associated with a resistance training regimen. At 1020 mg (3 capsules) daily: Helps support muscle tissue repair in individuals involved in resistance training. At 2040 mg (6 capsules) daily: May help promote an improvement in physical performance when used in conjunction with a training regimen. At 2040 mg (6 capsules) daily: May help delay fatigue during physical activity by increasing metabolisms of fats.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. If you have a pre-existing seizure disorder, liver or kidney disease, or if you have been instructed to follow a low-protein diet consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80041412
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.